Cepheid | search
Click here to view Cepheid news from 60+ newspapers.
Bookmark or Share- Enabling Access to Molecular Diagnostic Testing Everywhere - CepheidCepheid's GeneXpert® System is the world's most flexible platform, providing healthcare professionals with a best in class test menu for any setting — from the core lab to near patient applications. Find out why Cepheid's solutions are a top choice for fast, accurate, and easy diagnostic testing.
- Xpert® Xpress SARS-CoV-2 - FDA Emergency Use Authorization - CepheidXpert® Xpress CoV-2/Flu/RSV plus*. Meet the challenges of the ongoing pandemic with the confidence of a single test to detect and differentiate SARS-CoV-2, Flu A, Flu B, and RSV. Results for all four pathogens in just 36 minutes. * These tests have not been FDA cleared or approved.
- Xpert® Xpress CoV-2/Flu/RSV plus - CepheidThe Xpert Xpress CoV-2/Flu/RSV plus test: Provides fast and accurate results in as early as 25 minutes# for SARS-CoV-2. Utilizes a multi-gene target approach for the detection of SARS-CoV-2 and influenza providing target redundancy to mitigate the potential impact of genetic shift and drift on strain detection.
- Cepheid (company) - WikipediaCepheid [a] is an American molecular diagnostics company that is a wholly owned subsidiary of Danaher Corporation. Its systems automate traditional nucleic acid tests (tests for specific sequences of DNA or RNA ). The tests can be used to identify and analyze pathogens and genetic disorders.
- GeneXpert Molecular Diagnostic Testing Systems - CepheidCepheid's GeneXpert system with touchscreen combines speed, accuracy, simplicity, and an intuitive user interface to deliver PCR results anywhere testing is needed. Learn more
More
